About this trial
This study aims to determine whether Trinase, an enzyme-based anti-inflammatory medication, can reduce pain after root canal treatment in patients with symptomatic irreversible pulpitis. A total of 182 male patients aged 18 to 50 years who present with moderate to severe tooth pain will be randomly assigned to receive either a Trinase tablet or a placebo 30 minutes before treatment. All root canal procedures will be performed in a single visit using standard endodontic techniques.
Pain levels will be measured on a Visual Analogue Scale (VAS) before treatment and at 6, 12, 24, and 48 hours after treatment. Patients will also record the number of pain-relief tablets they take during the first 48 hours. The goal of the study is to see whether Trinase can lower post-operative pain and reduce the need for analgesic medication compared with placebo. This information may help improve pain management for patients undergoing root canal therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Systemically healthy male patients (ASA I or II)
Aged 18 to 50 years
Presenting with symptomatic irreversible pulpitis in a restorable mandibular molar
Preoperative moderate to severe pain (VAS ≥45 mm)
Disqualifiers
History of allergy or intolerance to Trinase or any of its components (trypsin, bromelain, rutin)
Vertical root fracture
External or internal root resorption
Periodontal pocket depth >5 mm
Trial design
Parallel
Treatments tested in this trial
Trinase
DrugOne tablet of Trinase (proteolytic enzyme combination: trypsin, bromelain, and rutin) administered orally 30 minutes prior to root canal treatment. Used as premedication to reduce postoperative pain and inflammation.
placebo capsule
DrugOne identical-appearing placebo tablet administered orally 30 minutes prior to root canal treatment. Used as control.
Treatment groups
Trial outcomes
Primary outcomes
Post-operative pain intensity assessed by Visual Analogue Scale (VAS)
Pain intensity recorded by patients on a 10-cm Visual Analogue Scale (VAS) where 0 = no pain and 100 = pain as bad as it could be. Scores categorized as: no pain (0-4 mm), mild (5-44 mm), moderate (45-74 mm), severe (75-100 mm). Measured at baseline and post-operatively.
Secondary outcomes
Number of analgesic tablets consumed within 48 hours post-treatment
Total number of rescue analgesic tablets (Trinase) taken by patients within 48 hours after root canal treatment, as recorded on provided charts during follow-up.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.